We are live on ! Find out more
RVMD icon

Revolution Medicines
RVMD

128 hedge funds and large institutions have $3.05B invested in Revolution Medicines in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 51 increasing their positions, 23 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,277% more call options, than puts

Call options by funds: $9.6M | Put options by funds: $404K

122% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 23

45% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 20

34% more capital invested

Capital invested by funds: $2.27B → $3.05B (+$775M)

8% more funds holding

Funds holding: 119 → 128 (+9)

4.05% more ownership

Funds ownership: 86.51% → 90.57% (+4.1%)

17% less funds holding in top 10

Funds holding in top 10: 12 → 10 (-2)

Holders
128
Holders Change
+9
Holders Change %
+7.56%
% of All Funds
2.25%
Holding in Top 10
10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-16.67%
% of All Funds
0.18%
New
29
Increased
51
Reduced
23
Closed
20
Calls
$9.6M
Puts
$404K
Net Calls
+$9.2M
Net Calls Change
+$9.18M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$165M
2
FCM
Farallon Capital Management
California
+$72.2M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$66.9M
4
BG
Bellevue Group
Switzerland
+$46M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$36.4M

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP III
Massachusetts
-$67.3M
2
SAM
Sectoral Asset Management
Quebec, Canada
-$15.4M
3
PA
Perceptive Advisors
New York
-$8.88M
4
PHS
PFM Health Sciences
California
-$8.28M
5
PI
Putnam Investments
Massachusetts
-$7.93M
Name Holding Trade Value Shares
Change 		Change in
Stake
HMC
26
Harvard Management Company
Massachusetts
$30.8M – – –
Northern Trust
27
Northern Trust
Illinois
$21.6M +$1.24M +27,583 +6%
Bessemer Group
28
Bessemer Group
New Jersey
$20.1M -$5.08M -113,197 -21%
Ameriprise
29
Ameriprise
Minnesota
$19.3M +$6.67M +148,682 +55%
Charles Schwab
30
Charles Schwab
California
$14.4M +$2.14M +47,735 +18%
First Trust Advisors
31
First Trust Advisors
Illinois
$10.3M +$5.43M +121,023 +117%
BBA
32
Baker Bros. Advisors
New York
$10.2M +$9.97M +222,222 New
N
33
Nuveen
North Carolina
$9.52M +$2.44M +54,518 +36%
DCM
34
Driehaus Capital Management
Illinois
$9.44M +$9.23M +205,788 New
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$8.53M +$7.67M +171,148 +1,156%
Norges Bank
36
Norges Bank
Norway
$7.74M +$7.57M +168,734 New
Morgan Stanley
37
Morgan Stanley
New York
$7.31M +$5.79M +129,118 +427%
DCM
38
DAFNA Capital Management
California
$6.94M +$5.77M +128,731 +572%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$6.51M +$201K +4,493 +3%
OCA
40
Octagon Capital Advisors
New York
$5.79M – – –
Balyasny Asset Management
41
Balyasny Asset Management
Illinois
$5.51M +$5.38M +120,052 New
JMPWA
42
JP Morgan Private Wealth Advisors
California
$4.76M -$246K -5,477 -5%
Citigroup
43
Citigroup
New York
$4.17M +$3.61M +80,526 +769%
Deutsche Bank
44
Deutsche Bank
Germany
$3.66M +$2.06M +46,045 +137%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$3.48M -$325K -7,240 -9%
Rafferty Asset Management
46
Rafferty Asset Management
New York
$3.21M +$2.42M +53,992 +336%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$2.96M +$255K +5,688 +10%
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$2.64M +$143K +3,200 +6%
AllianceBernstein
49
AllianceBernstein
Tennessee
$2.62M +$40.4K +900 +2%
SCM
50
Soleus Capital Management
Connecticut
$2.62M +$2.57M +57,200 New
1
2
3 4 5

RVMD Hedge Fund Activity: Q1 2021 in Review

128 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines (RVMD) for Q1 2021, worth a combined $3.05B — up 34% from $2.27B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new RVMD positions and 20 closed out — a net gain of 9 holders — while 51 added to existing stakes and 23 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $165M. The largest seller was TRV GP III, cutting an estimated $67.3M.

  • 128 institutional investors held Revolution Medicines (RVMD) as of Q1 2021, up from 119 in Q4 2020.
  • Funds reported $3.05B of Revolution Medicines stock for Q1 2021, up 34% quarter-over-quarter.
  • 29 funds opened new Revolution Medicines positions in Q1 2021 and 20 closed out, a net change of +9 holders.
  • The largest Revolution Medicines buyer in Q1 2021 was Wellington Management Group, an estimated $165M added.
  • The largest Revolution Medicines seller in Q1 2021 was TRV GP III, an estimated $67.3M sold.

Based on aggregated 13F filings for Q1 2021.